Italian oncology focused biotech Nerviano Medical Sciences yesterday announced that it has successfully negotiated with ...

Eisbach Bio's innovative approach focuses on exploiting the unique genetic vulnerabilities present in solid tumors with deficiencies in certain DNA repair pathways. Eisbach's proprietary ALLOS ...

Myriad Genetics incorporates its proprietary HRD platform in Illumina's updated TruSight Oncology 500 v2 comprehensive gene panel assay.